28083 Search Results


soybean plants  (ATCC)
90
ATCC soybean plants
Soybean Plants, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/soybean plants/product/ATCC
Average 90 stars, based on 1 article reviews
soybean plants - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
antibodies against cd31  (Proteintech)
96
Proteintech antibodies against cd31
Figure 2. rC6ORF120 induced the EndMT in HUVECs. (A) Representative western blot images of endothelial <t>(CD31</t> and VE‑cadherin) and mesenchymal (Vimentin and α‑SMA) marker proteins in HUVECs following treatment with rC6ORF120 and TGF‑β1. (B‑E) Corresponding bar graph representing rela tive expression of protein expression levels, normalized to GAPDH. *P<0.05; **P<0.01; ***P<0.001. rC6ORF120, recombinant C6ORF120 protein; EndMT, endothelial‑mesenchymal transition; HUVECs, human umbilical vein endothelial cells; α‑SMA, α‑smooth muscle actin.
Antibodies Against Cd31, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against cd31/product/Proteintech
Average 96 stars, based on 1 article reviews
antibodies against cd31 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

Image Search Results


Figure 2. rC6ORF120 induced the EndMT in HUVECs. (A) Representative western blot images of endothelial (CD31 and VE‑cadherin) and mesenchymal (Vimentin and α‑SMA) marker proteins in HUVECs following treatment with rC6ORF120 and TGF‑β1. (B‑E) Corresponding bar graph representing rela tive expression of protein expression levels, normalized to GAPDH. *P<0.05; **P<0.01; ***P<0.001. rC6ORF120, recombinant C6ORF120 protein; EndMT, endothelial‑mesenchymal transition; HUVECs, human umbilical vein endothelial cells; α‑SMA, α‑smooth muscle actin.

Journal: Molecular medicine reports

Article Title: Recombinant chromosome 6 open reading frame 120 protein promotes angiogenesis and endothelial‑to‑mesenchymal transition in human umbilical vein endothelial cells via the PI3K/Akt signaling pathway.

doi: 10.3892/mmr.2025.13596

Figure Lengend Snippet: Figure 2. rC6ORF120 induced the EndMT in HUVECs. (A) Representative western blot images of endothelial (CD31 and VE‑cadherin) and mesenchymal (Vimentin and α‑SMA) marker proteins in HUVECs following treatment with rC6ORF120 and TGF‑β1. (B‑E) Corresponding bar graph representing rela tive expression of protein expression levels, normalized to GAPDH. *P<0.05; **P<0.01; ***P<0.001. rC6ORF120, recombinant C6ORF120 protein; EndMT, endothelial‑mesenchymal transition; HUVECs, human umbilical vein endothelial cells; α‑SMA, α‑smooth muscle actin.

Article Snippet: After blocking with 5% skimmed milk for 1 h at room temperature, membranes were incubated overnight at 4 ̊C with primary antibodies against CD31 (cat. no. 28083‐1‐AP; 1:1,000; Proteintech Group, Inc.), VE‐cadherin (cat. no. 66804‐1‐IG; 1:1,000; Proteintech Group, Inc.), Vimentin (cat. no. 10366‐1‐AP; 1:5,000; Proteintech Group, Inc.), α‐smooth muscle actin (α‐SMA; cat. no. 67735‐1‐IG; 1:5,000; Proteintech Group, Inc.), AKT (cat. no. 60203‐2‐Ig; 1:1,000; Proteintech Group, Inc.), phos‐ phorylated (p‐)AKT (cat. no. 66444‐1‐Ig; 1:1,000; Proteintech Group, Inc.), PI3K (cat. no. 60225‐1‐Ig; 1:1,000; Proteintech Group, Inc.), p‐PI3K (cat. no. ab182651; 1:1,000; Abcam) and GAPDH (cat. no. 60004‐1‐Ig; 1:5,000; Proteintech Group, Inc.).

Techniques: Western Blot, Marker, Expressing, Recombinant

Figure 3. rC6ORF120 alters the fluorescence intensity of EndMT markers. Immunocytofluorescence staining of (A) α‑SMA and (C) CD31 in HUVECs following rC6ORF120 treatment, with (B and D) corresponding statistical analysis. **P<0.01; ***P<0.001. Scale bar, 200 µm. rC6ORF120, recombinant C6ORF120 protein; EndMT, endothelial‑mesenchymal transition; HUVECs, human umbilical vein endothelial cells.

Journal: Molecular medicine reports

Article Title: Recombinant chromosome 6 open reading frame 120 protein promotes angiogenesis and endothelial‑to‑mesenchymal transition in human umbilical vein endothelial cells via the PI3K/Akt signaling pathway.

doi: 10.3892/mmr.2025.13596

Figure Lengend Snippet: Figure 3. rC6ORF120 alters the fluorescence intensity of EndMT markers. Immunocytofluorescence staining of (A) α‑SMA and (C) CD31 in HUVECs following rC6ORF120 treatment, with (B and D) corresponding statistical analysis. **P<0.01; ***P<0.001. Scale bar, 200 µm. rC6ORF120, recombinant C6ORF120 protein; EndMT, endothelial‑mesenchymal transition; HUVECs, human umbilical vein endothelial cells.

Article Snippet: After blocking with 5% skimmed milk for 1 h at room temperature, membranes were incubated overnight at 4 ̊C with primary antibodies against CD31 (cat. no. 28083‐1‐AP; 1:1,000; Proteintech Group, Inc.), VE‐cadherin (cat. no. 66804‐1‐IG; 1:1,000; Proteintech Group, Inc.), Vimentin (cat. no. 10366‐1‐AP; 1:5,000; Proteintech Group, Inc.), α‐smooth muscle actin (α‐SMA; cat. no. 67735‐1‐IG; 1:5,000; Proteintech Group, Inc.), AKT (cat. no. 60203‐2‐Ig; 1:1,000; Proteintech Group, Inc.), phos‐ phorylated (p‐)AKT (cat. no. 66444‐1‐Ig; 1:1,000; Proteintech Group, Inc.), PI3K (cat. no. 60225‐1‐Ig; 1:1,000; Proteintech Group, Inc.), p‐PI3K (cat. no. ab182651; 1:1,000; Abcam) and GAPDH (cat. no. 60004‐1‐Ig; 1:5,000; Proteintech Group, Inc.).

Techniques: Fluorescence, Staining, Recombinant

Figure 7. Inhibition of the PI3K/Akt pathway reverses the induction of EndMT by rC6ORF120. Immunofluorescence analysis of (A) α‑SMA and (C) CD31. The bar graphs depict the relative fluorescence intensity of (B) α‑SMA and (D) CD31. ns indicates no statistically significant difference; ***P<0.001. Scale bar, 200 µm. EndMT, endothelial‑mesenchymal transition; rC6ORF120, recombinant C6ORF120 protein; α‑SMA, α‑smooth muscle actin.

Journal: Molecular medicine reports

Article Title: Recombinant chromosome 6 open reading frame 120 protein promotes angiogenesis and endothelial‑to‑mesenchymal transition in human umbilical vein endothelial cells via the PI3K/Akt signaling pathway.

doi: 10.3892/mmr.2025.13596

Figure Lengend Snippet: Figure 7. Inhibition of the PI3K/Akt pathway reverses the induction of EndMT by rC6ORF120. Immunofluorescence analysis of (A) α‑SMA and (C) CD31. The bar graphs depict the relative fluorescence intensity of (B) α‑SMA and (D) CD31. ns indicates no statistically significant difference; ***P<0.001. Scale bar, 200 µm. EndMT, endothelial‑mesenchymal transition; rC6ORF120, recombinant C6ORF120 protein; α‑SMA, α‑smooth muscle actin.

Article Snippet: After blocking with 5% skimmed milk for 1 h at room temperature, membranes were incubated overnight at 4 ̊C with primary antibodies against CD31 (cat. no. 28083‐1‐AP; 1:1,000; Proteintech Group, Inc.), VE‐cadherin (cat. no. 66804‐1‐IG; 1:1,000; Proteintech Group, Inc.), Vimentin (cat. no. 10366‐1‐AP; 1:5,000; Proteintech Group, Inc.), α‐smooth muscle actin (α‐SMA; cat. no. 67735‐1‐IG; 1:5,000; Proteintech Group, Inc.), AKT (cat. no. 60203‐2‐Ig; 1:1,000; Proteintech Group, Inc.), phos‐ phorylated (p‐)AKT (cat. no. 66444‐1‐Ig; 1:1,000; Proteintech Group, Inc.), PI3K (cat. no. 60225‐1‐Ig; 1:1,000; Proteintech Group, Inc.), p‐PI3K (cat. no. ab182651; 1:1,000; Abcam) and GAPDH (cat. no. 60004‐1‐Ig; 1:5,000; Proteintech Group, Inc.).

Techniques: Inhibition, Immunofluorescence, Fluorescence, Recombinant